(Medriva) – Recent studies have revealed a new beacon of hope for special operations military veterans suffering from traumatic brain injuries (TBI).
The psychoactive drug Ibogaine, derived from the iboga plant, has demonstrated significant potential in the treatment of this debilitating condition according to research published in Nature Medicine.
Researchers from Stanford Medicine explored the effectiveness of Ibogaine, in combination with magnesium to safeguard the heart.
The study comprised of 30 veterans from U.S. special forces who exhibited notable improvements in PTSD, depression, anxiety, and general functioning after undergoing treatment with Ibogaine. CONTINUE